# Ixabepilone

## Ixempra inj 15mg (2mg/mL)

| 藥物代碼           | IIXE                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症             | Breast cancer (metastatic or locally advanced)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 副作用             | >10%: Peripheral neuropathy (63%; grades 3/4: 14%; grade 3/4 median onset: Cycle 4), peripheral sensory neuropathy (62%; grades 3/4: 14%), headache (11%), Alopecia (48%), Nausea (42%), vomiting (29%), mucositis (?29%), stomatitis (?29%), diarrhea (22%), anorexia (19%), constipation (16%), abdominal pain (13%), Leukopenia (grade 3: 36%; grade 4: 13%), neutropenia (grade 3: 31%; grade 4: 23%), Weakness (56%), arthralgia (?49%), myalgia (?49%), musculoskeletal pain (20%)1% to 10%:Edema (9%), chest pain (5%), Peripheral motor neuropathy (10%; grade 3: 1%), pain (8%), dizziness (7%), insomnia (5%),  Nail disease (9%), skin rash (9%), palmar-plantar erythrodysesthesia (8%), pruritus (6%), desquamation (2%), hyperpigmentation (2%), Hot flash (6%), weight loss (6%), dehydration (2%), Dysgeusia (6%), gastroesophageal reflux (6%), Anemia (grade 3: 6%; grade 4: 2%), febrile neutropenia (3%; grade 3: 3%), thrombocytopenia (grade 3: 5%; grade 4: 2%), Hypersensitivity (5%; grade 3: 1%), Infection (5%), Increased lacrimation (4%), Dyspnea (9%), upper respiratory tract infection (6%), cough (2%), Fever (8%)<1%, postmarketing, and/or case reports: Acute hepatic failure, acute pulmonary edema, angina pectoris, atrial flutter, autonomic neuropathy, blood coagulation disorder, cardiomyopathy, cerebral hemorrhage, colitis, delayed gastric emptying, dysphagia, embolism, enterocolitis, erythema multiforme, gastrointestinal hemorrhage, hemorrhage, hypokalemia, hyponatremia, hypotension, hypovolemia, hypovolemic shock, hypoxia, increased gamma-glutamyl transferase, increased serum alkaline phosphatase, increased serum transaminases, interstitial pneumonitis, intestinal obstruction, jaundice, left ventricular dysfunction, metabolic acidosis, myocardial infarction, nephrolithiasis, neutropenic infection, orthostatic hypotension, pneumonia, pneumonitis, radiation recall phenomenon, renal failure, respiratory failure, sepsis, septic shock, supraventricular cardiac arrhythmia, syncope, thrombosis, trismus, urinary tract infection, vasculitis, voice disorder |
| 禁忌               | History of severe (grade 3 or 4) hypersensitivity to polyoxyethylated castor oil (Cremophor EL) or its derivatives; neutrophil count <1,500/mm3 or platelet count <100,000/mm3; combination therapy with ixabepilone and capecitabine in patients with AST or ALT >2.5 times ULN or bilirubin >1 times ULN                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 藥物保存方式       | 冷藏2-8°C保存                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 用法用量           | Metastatic or locally advanced breast cancer : IV: 40 mg/m2/dose over 3 hours every 3 weeks (maximum dose: 88 mg) either as monotherapy or in combination with capecitabine                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 肝功能異常         | 需 調 整 劑 量  Monotherapy (initial cycle; adjust doses for subsequent cycles based on toxicity): AST and ALT 2.5 times ULN and bilirubin 1 times ULN: No dosage adjustment necessary AST and ALT >2.5 to 10 times ULN and bilirubin >1 to 1.5 times ULN: Reduce dose to 32 mg/m2 AST and ALT 10 times ULN and bilirubin >1.5 to ?3 times ULN: Reduce dose to 20 to 30 mg/m2 (initiate treatment at 20 mg/m2, may escalate up to a maximum of 30 mg/m2 in subsequent cycles if tolerated) AST or ALT >10 times ULN or bilirubin >3 times ULN: Use is not recommended Combination therapy with capecitabine: AST and ALT 2.5 times ULN and bilirubin 1 times ULN: No dosage adjustment necessary AST or ALT >2.5 times ULN or bilirubin >1 times ULN: Use is contraindicated                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 腎功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 懷孕用藥危分級     | 儘量避免                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 孕期用藥建議       | No (Limited) Human Data - animal data suggest moderate risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 哺乳期用藥建議     | Contraindicated 哺乳期使用禁忌                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 注射劑給藥建議途徑 | IVD                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 乾粉稀釋液         | 使用包裝內附8mL稀釋液溶解乾粉，稀釋液從冰箱取出須靜置30分鐘，回到室溫後使用。                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 輸注點滴液         | 【L/R】 可選 仿單建議  【N/S】 可選 仿單建議                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| IVP 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| IVD 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 注意事項           | 1.使用0.9% Normal saline作為點滴液時,必須借由加入2mEq的碳酸氫鈉注射液將pH值調整成6.0-9.0之間. 2.本藥品需裝於不含DEHP的包裝中. 3.為容許抽取損失,本品包裝內含16mg Ixabepilone,加入8mL稀釋液後,配製成濃度2mg/mL. 4.配製本藥時,將8mL稀釋液抽取並注入藥瓶中,已輕輕旋轉及翻轉藥瓶的方式直到完全溶解.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |

